InvestorsHub Logo
Followers 22
Posts 999
Boards Moderated 0
Alias Born 07/23/2017

Re: ragsandbones post# 68347

Thursday, 03/26/2020 3:00:31 AM

Thursday, March 26, 2020 3:00:31 AM

Post# of 94101
We all wish we could see the accounting books of RSAMMD, but of course, this is not likely to happen since they are a privately owned company. However, based on old numbers found on RSA’s website it looks like RSAMMD produced 37 KG/yr cannabis several years ago. This is likely much more now. The closest comparison company with similar cannabis production I know of is Tilray. Latest 2020 Tilray PR says they ramped up their production to only 35KG/yr. I’m estimating RSAMMD does 40+ KG per year now. Since Tilray is an almost $200M revenue company I think RSA is bigger. That’s $200M+. Not shabby and certainly enough to take Protext extraction technology Global. $$$$$ The real question is... what can we predict as a 1 year target PPS for Protext with ongoing perpetual royalty payments, A large upfront Licensing payment and Milestone sales payments, assuming this will be like other Pharma technology exploitation deals. The future is bright for Protext Pharma. $$$$$